ANIX (anixa.com) קפיטליזציה חשבונאית

Anixa Biosciences, Inc. (ANIX) automates the development of breast tumor medications using AI, although final medical oversight remains with specialists. The brand's high authority in precision oncology is supported by the development of advanced vaccines for the prevention of women's diseases. The indicator is 0.01. The company maintains a minimal headcount through outsourcing and options. The share price history is presented below.

Book value capitalization determines the objective value of net assets, excluding market volatility. This indicator aggregates the difference between all corporate assets and liabilities. By analyzing the book value profile, an investor can discern the actual volume of the company's own equity. For Anixa Biosciences, Inc. (ANIX), this metric reflects the financial resources available to conduct costly clinical trials for vaccines. The stability of this metric is critical until CAR-T therapy receives approval from insurance funds.